Late angioedema caused by ACE inhibitors underestimated [1]

American Family Physician

Volumn 66, Issue 6, 2002, Pages

  Pavletic, Adriana ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; STEROID;

ABDOMINAL PAIN; ANGIONEUROTIC EDEMA; CLINICAL FEATURE; HIGH RISK POPULATION; HUMAN; LAPAROTOMY; LETTER; NEGRO; PATHOGENESIS; PREVALENCE;

ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HUMANS; TIME FACTORS;

EID: 0037106351     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 1998;18:171-88.
2. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 2001;24:599-606.
3. Cohen EG, Soliman AM. Changing trends in angioedema. Ann Otol Rhinol Laryngol 2001;110:701-6.
4. Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin-converting enzyme inhibitor-associated angioedema. JAMA 1997;278:232-3.
5. Dean DE, Schultz DL, Powers RH. Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci 2001;46:1239-43.
6. Byrne TJ, Douglas DD, Landis ME, Heppell JP. Isolated visceral angioedema: an underdiagnosed complication of ACE inhibitors? Mayo Clin Proc 2000;75:1201-4.